article thumbnail

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 166
article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. Could our society miss out on potential medical breakthroughs due to outdated marijuana laws or strict regulations? In the saga of prohibition, here’s the latest news.

DEA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DEA Proposes Dramatic Increase In Marijuana And Psychedelic Production In 2022, Calling For 6,300 Percent More MDMA Alone

Cannabis Law Report

Marijuana Moment report. The Drug Enforcement Administration (DEA) is proposing a dramatic increase in the legal production of marijuana and psychedelics like psilocybin, LSD, MDMA and DMT to be used in research next year. Marijuana itself would get a 60 percent boost under DEA’s proposal, up to 3.2

DEA 96
article thumbnail

DEA Publishes Notice of Proposed Rulemaking On Marijuana Research

Cannabis Law Report

The USA’s Drug Enforcement Administration and Department of Justice have published a Notice of Proposed Rulemaking regarding scientific and medical research on marijuana. Last September, it indicated it would “facilitate and expand” scientific and medical marijuana research and last week saw another tentative step in that direction.

DEA 80
article thumbnail

DEA Declares Marijuana Seeds Below THC Limit are Legal Hemp

Cannabis Law Report

A January letter from the Drug Enforcement Agency (DEA) revealed its official stance that marijuana seeds with a delta-9 tetrahydrocannabinol (THC) concentration lower than 0.3% This new guidance establishes that the legality of marijuana seeds, tissue culture, and other genetic material depends solely on delta-9 THC concentration.

DEA 52
article thumbnail

Press Release: DEA proposes process to expand marijuana research in the United States

Cannabis Law Report

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. This proposed rule will result in additional registered growers and a larger, more diverse variety of marijuana available for research.

DEA 97
article thumbnail

‘The Doors are Wide Open’: Denver Cannabis Company Gets DEA Approval To Expand Alzheimer’s Research

Cannabis Law Report

The Denver cannabis company MedPharm can now ramp up its research into the effects marijuana has on Alzheimer’s disease. The new DEA research license will now change that. It’s possible because of a new Schedule I Researcher License granted by the Drug Enforcement Administration. credit: CBS). credit: CBS).

DEA 105